Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.

Saved in:
Bibliographic Details
Title: Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
Authors: Yu J (AUTHOR), Tao Q (AUTHOR), Cheng YY (AUTHOR), Lee KY (AUTHOR), Ng SS (AUTHOR), Cheung KF (AUTHOR), Tian L (AUTHOR), Rha SY (AUTHOR), Neumann U (AUTHOR), Röcken C (AUTHOR), Ebert MP (AUTHOR), Chan FK (AUTHOR), Sung JJ (AUTHOR)
Source: Cancer (0008543X). 1/1/2009, Vol. 115 Issue 1, p49-60. 12p.
Database: Academic Search Ultimate
Description
ISSN:0008543X
DOI:10.1002/cncr.23989